Cardiovascular Diseases

At Diabeteszentrum Hamburg West, clinical research in cardiovascular diseases focuses on reducing major heart and blood vessel risks in people with atherosclerotic cardiovascular disease, heart failure, and related metabolic conditions. The trials are exploring new ways to lower LDL cholesterol and lipoprotein(a), while also evaluating whether emerging therapies can help prevent serious events such as heart attack and stroke.

  • Testing new treatments to lower cardiovascular risk in people with established heart and vessel disease
  • Studying therapies aimed at reducing LDL-C and lipoprotein(a) levels
  • Evaluating whether investigational approaches can help prevent major adverse cardiovascular events

This area includes research on ASCVD, prevention of heart failure, and broader strategies to improve long-term cardiovascular outcomes in patients with high risk.

Nutritional and Metabolic Diseases

The site conducts extensive studies in nutritional and metabolic diseases, especially obesity, overweight, and type 2 diabetes. Much of the work is centered on helping people achieve meaningful weight loss, improve glycemic control, and manage obesity-related complications through new treatment options.

  • Investigating therapies for weight loss in adults with overweight or obesity
  • Evaluating treatments for type 2 diabetes mellitus and improved blood sugar control
  • Studying approaches for people with obesity and related comorbidities

Research here also includes people living with type 1 diabetes, chronic weight management needs, and obesity linked to other health conditions, with the goal of improving everyday disease control and overall metabolic health.

Respiratory Tract Diseases

Research in respiratory tract diseases at this Hamburg site is strongly linked to obstructive sleep apnea, particularly in people who also have overweight or obesity. These studies are examining whether new therapies can improve sleep apnea severity while also supporting weight reduction and better overall health.

  • Studying treatment options for adults with obstructive sleep apnea and excess body weight
  • Assessing whether new therapies can improve the Apnea-Hypopnea Index
  • Exploring combined benefits for sleep-related breathing problems and weight management

The research includes both treated and untreated sleep apnea populations, reflecting a practical effort to improve symptoms and support better long-term outcomes in people with overlapping metabolic and respiratory disease.